First Clinical Evidence Offered That Inhibiting P-Selectin May Limit Myocardial Damage during PCI

Article Information

DOI 
http://dx.doi.org/10.1177/155989771302011
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Wayne Kuznar
  1. Jean-Claude Tardif, MD
    1. Montreal Heart Institute, Montreal, Quebec, Canada
View Full Text

Article usage

AbstractFullPDF
Apr 2015800
Jul 2015211
Aug 2015100
Oct 2015232
Total1343

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
First Clinical Evidence Offered That Inhibiting P-Selectin May Limit Myocardial Damage during PCI
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Interventional Techniques & Devices Myocardial Infarction
Cardiology Clinical Trials
Interventional Techniques & Devices
Cardiology & Cardiovascular Medicine
Myocardial Infarction
Cardiology Clinical Trials